EGFR and neoplasm: EGFR and erb-B2 were expressed in 34% and 17% of the specimens, but the authors could not demonstrate any association between EGFR expression or erbB2, and tumour depth, lymph node status, extracapsular invasion, recurrence, or survival [157].